What is the expected absolute effect of using ACE-inhibitor on reducing all-cause mortality for CKD stages 3-4?
The anticipated absolute effect of using ACE-inhibitor on reducing all-cause mortality for CKD stages 3-4 is from 86 fewer to 18 more, as indicated in Table 60 of the Treating Heart Failure Chronic Heart Failure NICE 2018 publication. The quality of the evidence is very low due to risk of bias and imprecision.